Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2024 |
|
Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al. | Engineering prostate cancer in vitro: what does it take? | 2023 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2023 |
|
Dr Deepali Pal
Dr Helen Blair
Sean Hockney
Dr Melanie Beckett
Mankaran Singh
et al. | hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia | 2022 |
|
